Skip to main content
Clinical Trials/ISRCTN77871064
ISRCTN77871064
Completed
未知

Experimental, prospective, open, monocenter, clinical trial for the evaluation of a novel cream used to improve the condition of seborrheic dermatitis topically applied on face and chest in patients with seborrheic dermatitis

ISDIN S.A.0 sites12 target enrollmentOctober 17, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Seborrheic dermatitis
Sponsor
ISDIN S.A.
Enrollment
12
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/31705438 (added 11/11/2019)

Registry
who.int
Start Date
October 17, 2019
End Date
April 1, 2019
Last Updated
6 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
ISDIN S.A.

Eligibility Criteria

Inclusion Criteria

  • 1\. Males in otherwise good health
  • 2\. Aged 21\-65 years at time of enrollment
  • 3\. Mild to moderate visible SD on face and chest area

Exclusion Criteria

  • 1\. Acute or chronic disease or medical condition that could put participant at risk in the opinion of the Principal Investigator or compromise study outcomes
  • 2\. History of allergic reactions, skin sensitization and/or known allergies to cosmetic ingredients, toiletries, sunscreens, etc.
  • 3\. Immunocompromised
  • 4\. Taking other medications (oral or topical) that could interfere with the interpretation of the results

Outcomes

Primary Outcomes

Not specified

Similar Trials